| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A peptide aldehyde that can inhibit proteasome and calpain activities, thereby potentially affecting the degradation of proteins targeted by FBXL21. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A boronic acid derivative that inhibits the 26S proteasome, which may indirectly affect the function of FBXL21 in protein ubiquitination. | ||||||
Lactacystin | 133343-34-7 | sc-3575 sc-3575A | 200 µg 1 mg | $188.00 $575.00 | 60 | |
A naturally occurring compound that irreversibly inhibits proteasome activity, thus could affect the turnover of proteins regulated by FBXL21. | ||||||
Epoxomicin | 134381-21-8 | sc-201298C sc-201298 sc-201298A sc-201298B | 50 µg 100 µg 250 µg 500 µg | $137.00 $219.00 $449.00 $506.00 | 19 | |
A selective proteasome inhibitor that could alter the degradation pathway of substrates tagged by FBXL21. | ||||||
Carfilzomib | 868540-17-4 | sc-396755 | 5 mg | $41.00 | ||
An epoxyketone-based proteasome inhibitor that could disrupt the degradation of FBXL21-labeled proteins. | ||||||
Oprozomib | 935888-69-0 | sc-477447 | 2.5 mg | $280.00 | ||
An oral proteasome inhibitor that, by inhibiting the proteasome, could potentially alter the activity of FBXL21. | ||||||
Ixazomib | 1072833-77-2 | sc-489103 sc-489103A | 10 mg 50 mg | $311.00 $719.00 | ||
A small-molecule proteasome inhibitor that could affect the degradation of proteins involved in the FBXL21 pathway. | ||||||
Delanzomib, free base | 847499-27-8 | sc-396774 sc-396774A | 5 mg 10 mg | $160.00 $300.00 | ||
A proteasome inhibitor that could influence the ubiquitin-proteasome system and thereby the function of FBXL21. | ||||||